Induction of FoxP3 Pre-mRNA Alternative Splicing to Enhance the Suppressive Activity of Regulatory T Cells from Amyotrophic Lateral Sclerosis Patients

• Published in: Biomedicines Vol. 12; no. 5; p. 1022
• Main Authors: Zhdanov, Dmitry D., Gladilina, Yulia A., Blinova, Varvara G., Abramova, Anna A., Shishparenok, Anastasia N., Eliseeva, Daria D.
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.05.2024
• Subjects: Alternative splicing; Amyotrophic lateral sclerosis; Antibodies; Apoptosis; Autoimmune diseases; CD25 antigen; CD4 antigen; Cell therapy; CTLA-4 protein; Development and progression; Disease; Endopeptidases; Ethylenediaminetetraacetic acid; Exons; Flow cytometry; Forkhead protein; FoxP3; Foxp3 protein; Gene expression; Immunoregulation; Lymphocytes; Lymphocytes T; Medical prognosis; Messenger RNA; Oligonucleotides; Perforin; Peripheral blood; Proteins; regulatory T cells; Serine proteinase; splicing-switching oligonucleotides; suppressive activity; T cells; Telomerase; Transcription factors; Germany; Russia; United States > US; regulatory T cells; splicing-switching oligonucleotides; alternative splicing; FoxP3; amyotrophic lateral sclerosis; suppressive activity
• DOI: 10.3390/biomedicines12051022
• ISSN: 2227-9059

Forkhead box protein 3 (FoxP3) is a key transcription factor responsible for the development, maturation, and function of regulatory T cells (Tregs). The FoxP3 pre-mRNA is subject to alternative splicing, resulting in the translation of multiple splice variants. We have shown that Tregs from patients with amyotrophic lateral sclerosis (ALS) have reduced expression of full-length (FL) FoxP3, while other truncated splice variants are expressed predominantly. A correlation was observed between the reduced number of Tregs in the peripheral blood of ALS patients, reduced total FoxP3 mRNA, and reduced mRNA of its FL splice variant. Induction of FL FoxP3 was achieved using splice-switching oligonucleotides capable of base pairing with FoxP3 pre-mRNA and selectively modulating the inclusion of exons 2 and 7 in the mature mRNA. Selective expression of FL FoxP3 resulted in the induction of CD127low, CD152, and Helios-positive cells, while the cell markers CD4 and CD25 were not altered. Such Tregs had an increased proliferative activity and a higher frequency of cell divisions per day. The increased suppressive activity of Tregs with the induced FL FoxP3 splice variant was associated with the increased synthesis of the pro-apoptotic granzymes A and B, and perforin, IL-10, and IL-35, which are responsible for contact-independent suppression, and with the increased ability to suppress telomerase in target cells. The upregulation of Treg suppressive and proliferative activity using splice-switching oligonucleotides to induce the predominant expression of the FoxP3 FL variant is a promising approach for regenerative cell therapy in Treg-associated diseases.